Jaideep Chanayil Menon, D.M.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Snake Bites | 9 | 2024 | 28 | 4.420 |
Why?
|
Antivenins | 5 | 2024 | 18 | 1.610 |
Why?
|
India | 25 | 2024 | 2349 | 1.330 |
Why?
|
Snake Venoms | 3 | 2022 | 40 | 0.840 |
Why?
|
Siblings | 1 | 2021 | 825 | 0.570 |
Why?
|
Coronary Artery Disease | 4 | 2024 | 6395 | 0.510 |
Why?
|
Medication Adherence | 1 | 2024 | 2176 | 0.410 |
Why?
|
Poverty Areas | 2 | 2023 | 267 | 0.380 |
Why?
|
Cost of Illness | 5 | 2023 | 1936 | 0.330 |
Why?
|
Hypertension | 5 | 2023 | 8542 | 0.320 |
Why?
|
Diabetes Mellitus | 3 | 2022 | 5840 | 0.320 |
Why?
|
Multicenter Studies as Topic | 2 | 2024 | 1703 | 0.300 |
Why?
|
Snakes | 3 | 2022 | 30 | 0.300 |
Why?
|
Rural Population | 4 | 2024 | 2285 | 0.290 |
Why?
|
Viper Venoms | 2 | 2024 | 15 | 0.290 |
Why?
|
Pandemics | 4 | 2023 | 8641 | 0.280 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2024 | 10203 | 0.280 |
Why?
|
Public Health | 1 | 2020 | 2666 | 0.280 |
Why?
|
Cardiovascular Diseases | 4 | 2024 | 15498 | 0.280 |
Why?
|
L-Amino Acid Oxidase | 1 | 2024 | 6 | 0.250 |
Why?
|
Viperidae | 1 | 2024 | 4 | 0.250 |
Why?
|
Phospholipases A2 | 1 | 2024 | 197 | 0.230 |
Why?
|
Poverty | 1 | 2015 | 2697 | 0.210 |
Why?
|
Reminder Systems | 2 | 2024 | 388 | 0.210 |
Why?
|
House Calls | 1 | 2024 | 161 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3082 | 0.210 |
Why?
|
Cross Reactions | 1 | 2024 | 818 | 0.200 |
Why?
|
Stroke | 2 | 2015 | 9756 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3202 | 0.200 |
Why?
|
Technology Assessment, Biomedical | 1 | 2024 | 307 | 0.200 |
Why?
|
Cross-Sectional Studies | 7 | 2024 | 26112 | 0.190 |
Why?
|
Population Surveillance | 3 | 2016 | 2597 | 0.180 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 3204 | 0.170 |
Why?
|
Reptilian Proteins | 1 | 2019 | 5 | 0.170 |
Why?
|
Hypertension, Pulmonary | 2 | 2021 | 1580 | 0.160 |
Why?
|
Quality-Adjusted Life Years | 2 | 2023 | 1722 | 0.160 |
Why?
|
Blister | 1 | 2019 | 86 | 0.160 |
Why?
|
Life Expectancy | 2 | 2023 | 1242 | 0.160 |
Why?
|
Smoking | 1 | 2015 | 9052 | 0.150 |
Why?
|
Capillary Leak Syndrome | 1 | 2018 | 34 | 0.150 |
Why?
|
Cardiovascular Agents | 1 | 2024 | 840 | 0.150 |
Why?
|
Myocardial Infarction | 2 | 2019 | 11458 | 0.150 |
Why?
|
Telemedicine | 3 | 2024 | 3051 | 0.150 |
Why?
|
Humans | 31 | 2024 | 761423 | 0.140 |
Why?
|
Rural Health | 1 | 2016 | 297 | 0.120 |
Why?
|
Registries | 4 | 2021 | 8223 | 0.120 |
Why?
|
Risk Factors | 6 | 2023 | 74167 | 0.110 |
Why?
|
Culture | 1 | 2017 | 623 | 0.110 |
Why?
|
Incidence | 2 | 2022 | 21341 | 0.110 |
Why?
|
Burnout, Professional | 1 | 2022 | 704 | 0.110 |
Why?
|
Health Services Accessibility | 4 | 2024 | 5441 | 0.100 |
Why?
|
Aged | 13 | 2024 | 169235 | 0.100 |
Why?
|
Adult | 16 | 2024 | 221148 | 0.100 |
Why?
|
Diabetic Retinopathy | 1 | 2022 | 1274 | 0.100 |
Why?
|
Socioeconomic Factors | 2 | 2017 | 7825 | 0.100 |
Why?
|
Cholesterol, LDL | 1 | 2021 | 2382 | 0.100 |
Why?
|
Cost-Benefit Analysis | 1 | 2024 | 5492 | 0.090 |
Why?
|
Coronary Angiography | 1 | 2022 | 4472 | 0.090 |
Why?
|
Community Health Services | 1 | 2015 | 656 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3204 | 0.090 |
Why?
|
Middle Aged | 15 | 2024 | 220826 | 0.080 |
Why?
|
Morbidity | 3 | 2023 | 1750 | 0.080 |
Why?
|
Proteome | 1 | 2019 | 1862 | 0.080 |
Why?
|
Health Personnel | 1 | 2022 | 3335 | 0.080 |
Why?
|
Male | 14 | 2024 | 360736 | 0.070 |
Why?
|
Health Policy | 1 | 2020 | 2684 | 0.070 |
Why?
|
Female | 15 | 2024 | 392581 | 0.070 |
Why?
|
Insurance, Health | 1 | 2019 | 2497 | 0.070 |
Why?
|
Health Expenditures | 1 | 2019 | 2366 | 0.070 |
Why?
|
Health Care Costs | 1 | 2019 | 3243 | 0.060 |
Why?
|
Regression Analysis | 1 | 2015 | 6343 | 0.060 |
Why?
|
Health Surveys | 1 | 2014 | 4059 | 0.060 |
Why?
|
Hyaluronoglucosaminidase | 1 | 2024 | 136 | 0.060 |
Why?
|
Prognosis | 2 | 2022 | 29620 | 0.060 |
Why?
|
Animals | 6 | 2024 | 168441 | 0.060 |
Why?
|
Gross Domestic Product | 1 | 2023 | 78 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2017 | 4014 | 0.050 |
Why?
|
Self-Help Groups | 1 | 2022 | 192 | 0.050 |
Why?
|
Risk Assessment | 1 | 2022 | 23990 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2024 | 58956 | 0.040 |
Why?
|
Species Specificity | 1 | 2024 | 2416 | 0.040 |
Why?
|
Qualitative Research | 2 | 2024 | 3023 | 0.040 |
Why?
|
Elapid Venoms | 1 | 2019 | 41 | 0.040 |
Why?
|
Acute Coronary Syndrome | 1 | 2012 | 2190 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2024 | 64651 | 0.040 |
Why?
|
Echocardiography, Doppler | 1 | 2021 | 898 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12143 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2015 | 5335 | 0.040 |
Why?
|
Heart Failure | 1 | 2021 | 11674 | 0.040 |
Why?
|
Lipoprotein(a) | 1 | 2022 | 480 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2024 | 3810 | 0.040 |
Why?
|
Blood Pressure | 2 | 2022 | 8487 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2022 | 80582 | 0.030 |
Why?
|
Urban Population | 1 | 2023 | 2036 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2022 | 2696 | 0.030 |
Why?
|
Cholesterol | 1 | 2022 | 2902 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2022 | 22168 | 0.030 |
Why?
|
Decision Making | 1 | 2024 | 3929 | 0.020 |
Why?
|
Mental Health | 1 | 2022 | 3249 | 0.020 |
Why?
|
Prevalence | 1 | 2023 | 15717 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2319 | 0.020 |
Why?
|
Proteomics | 1 | 2019 | 3845 | 0.020 |
Why?
|
Disease Management | 1 | 2015 | 2507 | 0.020 |
Why?
|
Prospective Studies | 2 | 2021 | 54415 | 0.010 |
Why?
|
Echocardiography | 1 | 2016 | 4991 | 0.010 |
Why?
|
Fibrinolytic Agents | 1 | 2012 | 2084 | 0.010 |
Why?
|
Depression | 1 | 2022 | 8122 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2015 | 3889 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12720 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12938 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2012 | 2751 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2012 | 5291 | 0.010 |
Why?
|
Infant | 1 | 2019 | 36205 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39117 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 42254 | 0.010 |
Why?
|
Hospitalization | 1 | 2012 | 10718 | 0.010 |
Why?
|
Young Adult | 1 | 2019 | 59207 | 0.010 |
Why?
|